chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a nurse referring to an unknown number of patients of unknown age and gender. No relevant medical history or concurrent conditions were reported. In June 2016 (reported as "within the past 3 days"), multiple patients were vaccinated with ROTATEQ (lot # L046318, expiration date 28-SEP-2017; oral, dose was not reported) which had been through a temperature excursion. The nurse reported that ROTATEQ with lot # reported as L035637, expiration date 09-JUN-2017, was also administered to multiple patients on multiple unknown dates following temperature excursion (temperature: 34 F 10 minutes; previous temperature excursion: 35 for 10 minutes; the call was not because of a data logger). No adverse effects were reported. Additional information is not expected as no consent was given to contact the physician.
Swelling feeling in back of throat, tongue within 5-10 minutes after shot and lasted about 3 hours. Weird taste in mouth like I drank the vaccine immediately after and lasted about 4 hours. Major headache about 45 minutes after shot and lasted about 10 hours.
Unexplained back pain started the following week. Two weeks after the Shingrix vaccine I awakened to a severe stabbing pain on left side of spine approximately near my 6th rib. Within the next week first an xray was done and then an MRI. I was put on Muscle relaxers and the two days later a 6 day Methy-Prednisone pack. (tests and medicines were prescribed by a different doctor's office then where I got the vaccine). # days after going off of Prednisone, pain became more severe again. for the next 5 days I alternated Ibuprofen and Tylenol, first every 3 hours, and then every 6 hours for the next week. At that time I was diagnosed with Rashless Shiingles (ZSH) and given 200mg of Gabepentin. Pain was becoming more diffuse spreading to underarm. I am going into 7 weeks after Shingrix vaccine and am about 60% better. Driving irritates pain as done leaning back on a chair.
2 hours after 2nd vaccination, "my" back spasmed; 2 hours after 2nd vaccination, "my" back spasmed and was uncomfortable; Since the 2nd vaccination, "my" left arm at injection site off and on feels like "I" had just received the injection.; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 30Mar2021 at 16:00 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. The medical history included thyroid and unspecified allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications included levothyroxine sodium (L-THYROXINE) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 11Mar2021 at 13:15 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. On 30Mar2021, at 18:00, 2 hours after 2nd vaccination, the patient's back spasmed and was uncomfortable and lifted about 6 hours later. Since the 2nd vaccination, the patient's left arm at injection site off and on felt like she had just received the injection. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left arm at injection site off and on felt like had just received the injection, back spasmed and uncomfortable were not resolved at the time of this report. The patient also received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 30130BA) via an unspecified route of administration in the right arm on 15Oct2021 at 10:30 (at the age of 68-years-old) as a single dose for COVID-19 immunisation.
Spouse was on schedule to receive 2nd dose of Pfizer vaccine. Was not showing for appointment so called to check if still able to come in. Stated unable too, but her husband needed his 2nd shot. Confirmed with spouse that husband had received the Pfizer vaccine and stated yes. Husband then scheduled to come to receive 2nd dose of Pfizer vaccine. Patient arrived without his card. On the screening questionnaire he filled out that he had received Pfizer for his first dose. When nurse went to check his first dose to then enter historically into our system, she noted it was Moderna, but she had already given Pfizer vaccine and patient had left. She alerted me to error.
This case was reported by a consumer via interactive digital media and described the occurrence of allergic reaction in a patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent).    On an unknown date, the patient received FluLaval Quadrivalent. On an unknown date, unknown after receiving FluLaval Quadrivalent, the patient experienced allergic reaction (serious criteria hospitalization). On an unknown date, the outcome of the allergic reaction was unknown.   It was unknown if the reporter considered the allergic reaction to be related to FluLaval Quadrivalent.  Additional details were provided as follows: The patient had reported the case for herself/himself. The age at vaccination was not reported. The patient had severe allergic reaction and needed to stay in hospital after receiving GSK FluLaval Quadrivalent vaccine. Follow-up would not possible, as no contact details were available.
felt lightheaded, tunneling of vision, sweating, no LOC--started to feel better after 5-10 minutes vitals stable juice given
This case was reported by a other health professional and described the occurrence of inappropriate age at vaccination in a female patient who received FLUARIX TETRA (batch number UI191AA?, expiry date unknown). On an unknown date, the patient received FLUARIX TETRA. On an unknown date, an unknown time after receiving FLUARIX TETRA, the patient experienced inappropriate age at vaccination. On an unknown date, the outcome of the inappropriate age at vaccination was unknown. It was unknown if the reporter considered the inappropriate age at vaccination to be related to FLUARIX TETRA. Additional information: A pediatric patient was inadvertently given an adult dose (0.5 mL) of FLUARIX QIV. No adverse event was reported.
She had a slight fever after administering vaccine. On Mar15 till 10:30PM she is doing good, working on household chores. All of a sudden she complained about a pain behind ear that creeped to her Head (Unbearable pain). With in a minute she became unconscious and we called 911, they took her to Medical Center and moved her to  another Medical Center Neurosurgeon is available. As per doctors, cause of death as per Death Certificate are as follows: Cerebral Herniation Malignant Cerebral Edema Anoxic Brain Injury Aneurysmal Subarachnoid Hemorrhage
the patient was administered improperly stored VARlVAX; This spontaneous report was received from a registered nurse, referring to a 15-year-old female patient. The patients' pertinent medical history, current conditions, previous drug reactions or allergies were not reported.   On 23-AUG-2020, at the age of 15-year-old the patient was administered improperly stored of varicella virus vaccine live (oka/merck) (VARIVAX), injection, administered subcutaneously (strength, dose, vaccination scheme, anatomical site of vaccination were not reported; lot number S030223, which has been verified to be valid, expiration date reported and validated as 26-SEP-2021) as propylaxis (product storage error), as concomitant therapy a properly stored of sterile diluent (MERCK STERILE DILUENT) injection (lot number S015772, which has been verified to be valid, expiration date reported and validated as 12-FEB-2022) was used as medication dilution to reconstitute the vaccine. The vaccine administered experienced a temperature and time frame from 9 degrees Celsius to 25C (8.7C) for 7 hours and 25 minutes, as recorded by a data logger. There was no previous temperature excursion reported.
Chills, Fever 100.8,   headache, lethargic body aches.
Sunday morning woke up with swollen checks (cheekbone areas)  in the same areas as having received Juvaderma Voluma fillers on June 16, 2020.  The right cheekbone was more swollen than the left but there was also a pocket of fluid under the right eye.  The areas were very tender to the touch.  Iced the areas for several minutes and called both Dr.'s office and the pharmacist and both told me to take Benedryl, which I did.  Has not helped.  Swelling remains as of Monday morning and the fluid under the right eye feels hard like a knot.  Seeing Dr.  this afternoon.
Itching; Swelling; This spontaneous case was reported by a physician and describes the occurrence of PRURITUS (Itching) and SWELLING (Swelling) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041LLZ0A) for COVID-19 vaccination.     Concomitant products included CLONAZEPAM and PREDNISONE for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PRURITUS (Itching) and SWELLING (Swelling). The patient was treated with CETIRIZINE HYDROCHLORIDE (CETRIZINE) at an unspecified dose and frequency; FAMOTIDINE at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BANOPHEN) at an unspecified dose and frequency. On 03-Mar-2021, PRURITUS (Itching) and SWELLING (Swelling) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Bexsero booster for a 53 y/o patient / Bexsero 5 years ago 1 month apart; whose specialist has written a prescription for her PCP to administer a Bexsero Booster; unaware if dose was administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 53-year-old female patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included Men B NVS (Bexsero) for prophylaxis and Men B NVS (Bexsero) for prophylaxis.   Concurrent medical conditions included immunocompromised and complement deficiency disease (C-2 Complement deficiency).   On an unknown date, the patient received Bexsero, the 2nd dose of Bexsero and the 1st dose of Bexsero. On an unknown date, an unknown time after receiving Bexsero, Bexsero and Bexsero, the patient experienced inappropriate age at vaccine administration (Verbatim: Bexsero booster for a 53 y/o patient / Bexsero 5 years ago 1 month apart), drug prescribing error (Verbatim: whose specialist has written a prescription for her PCP to administer a Bexsero Booster) and extra dose administered (Verbatim: unaware if dose was administered). The outcome of the inappropriate age at vaccine administration, drug prescribing error and extra dose administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 17-OCT-2023 Nurse requested data on administration of a Bexsero booster for a 53-year patient who was immunocompromised and has C-2 Complement deficiency, whose specialist had written a prescription for her primary care physician to administer a Bexsero Booster, which led to drug prescribing error. Patient received primary Bexsero 5 years ago 1 month apart.  The reporter asked was there any data regarding a Bexsero booster and timing of the booster vaccine, did the patient need the 2-part series or a single dose of Bexsero, Bexsero not given at the time of call, unaware if dose was administered or not to the patient. The reporter consented to follow up. The patient above recommended age received primary and booster, which led to inappropriate age at vaccine administration and extra dose administered.
Case number PHEH2013US016314, is an initial spontaneous report received from the pharmacist on 30 JUL 2013. This report refers to an 18 years old female patient. Past medical history and concomitant medication were not reported. She received only Men C, Y, W-135 liquid conjugate component of MENVEO (batch number X12097), intramuscularly on 29 JUL 2013. She did not received Men A lyophilized conjugate vaccine component of MENVEO. No adverse event was reported following this administration error.
On 27 Oct 14, patient received yellow fever and meningococcal vaccines on their right arm. He received typhoid vaccine in left arm and the nasal Flumist. On 29 Oct 14, patient states he noticed some bumps on his right arm (forearm and elbow) that itched. Patient states over the course of the day, they swelled very large.  On 31 Oct 14, patient states he noticed more bumps and rashes on his right arm and right side that also itched.  Patient states that starting on 29 Oct 14, he also had soreness in all of his joints. Patient was seen on 3 Nov 14 by a physician. Patient was told to keep an eye on it. Patient was also told to report to immunization's clinic to file VAERS report.
Patient called 24 hours after receiving the vaccine and stated she had dry eyes or blisters in her eyes. Instructed her to go to her primary physician. Primary physician stated she had dry eyes and gave her eye drops. Unsure if related to FLUMIST.
Patient experienced pain to the injection site, cool items relieved pain. By 1/24/2019 patient said she was 50% better.
Sensation of tightening in throat and sensation of difficulty swallowing. No rash. No dyspnea. No stridor/wheezing.  Vital signs unremarkable. Suspect globus sensation. Plan observation until resolution or progression to anaphylaxis.
Body aches; Migrating joint pain; Significant swelling of the lymph nodes in left arm pit; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 28Apr2021 at 08:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included an unspecified birth control pill on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 07Apr2021 at 08:45 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. On 28Apr2021 at 18:00, the patient experienced body aches, migrating joint pain and significant swelling of the lymph nodes in left arm pit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, migrating joint pain and significant swelling of the lymph nodes in left arm pit were resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
Information has been received from a certified medical assistant concerning a 52 year old female with diabetes and high cholesterol, who on 28-AUG-2007 was vaccinated with a 0.5mL dose of PNEUMOVAX 23 (Lot# 658074/0961U).  Subsequently, the patient complained of a swollen red hot left arm.  At the time of the report, the patient's outcome was unknown.  This report is one report of three received by the same source.  Additional information has been requested.
then I got the pfizer booster; then I got the pfizer booster; I am so miserable; This is a spontaneous report from a contactable consumer (patient). A 92-years-old non-pregnant female patient received third dose (Booster dose) of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported, patient was 92-year-old at the time of vaccination), via an unspecified route of administration on an unspecified date in 2021 as DOSE 3 (BOOSTER), SINGLE for covid-19 immunisation. Medical history included atrial fibrillation. Concomitant medication(s) included warfarin sodium (COUMADIN); losartan (LOSARTAN); bisoprolol fumarate, hydrochlorothiazide (BISOPROLOL /HCTZ) all were taken for an unspecified indication received within 2 weeks of vaccination, start and stop date were not reported. Reported that patient started itching all over, no rash. It has kept me up at night (it's the worse at night) but I itch all day. After a couple of weeks, I got a rash; thinking it was where I would scratch. I went to several dermatologist and nothing. I got off the bisoprl; thinking that was it. I got the second shot and then I got the Pfizer booster, and my daughter gave me a printout saying itching and rash were side effects of the shots. If I had known that; I wouldn't have taken it. I am so miserable. Creams from dermatologist doesn't work. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot number: EL3248, patient was 92-year-old at the time of vaccination), via an unspecified route of administration, administered on left arm on 13Jan2021 at 15:15 as DOSE 1, SINGLE for covid-19 immunisation and experienced Itching all over and Rash on 20Jan2021 at 08:00 PM which resulted in to visit doctor or other healthcare professional office/clinic visit having treatment with unspecified creams with outcome not recovered; and second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, on an unspecified date in 2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19; since the vaccination, the patient was not tested for COVID-19. On an unspecified date in 2021, the patient experienced then i got the Pfizer booster, i am so miserable. The outcomes of events were unknown.
pt's leg became red,swollen & warm to touch;mom gave APAP & used warm compresses to the lt leg;mom described pt having temp of 101;pt devel diarrhea on exam;3in x 3/4 warm red lesion lt ant thigh,perirectal rash
Began with extreme chills, teeth chattering 0500 for 1 hour Accompanied by extreme thirst, 2 hours with drinking water Fatigue, slept until 1330 Walked into bathroom, lost coordination and muscle strength, fell onto floor No strength, laid on floor until 2230 Wife called 911, EMT's lifted to standing position, did assessment and left, stood and walked as normal Went to sleep, 9 hours, awoke with full function 0800
I'm breastfeeding and my newborn since my 2nd dose has been vomiting and spitting up alot since the vaccine .
I had a heart attack on 8/1. On July 27th I had an abnormal stress test. I had a scheduled Cath to check on blockage but a few days before that procedure I was having chest pains and went to the ER where my DR is located. I was transported to the heart and lung center and the next day had a Cath and a stent. After that all my biomarkers went back to normal.
Irregular Menstrual cycle  I have had a regular menstrual  cycle since 11 years old.  I received the second Moderna shot on March 27. I was on my period/cycle on my shot date- March 27, 2021.. I starts very light bleeding on Saturday April 17th- the bleeding has increased and is very heavy today (4/21). I have symptoms of my normal cycles but the symptoms seem more painful/intense- stomach ache, fatigue,  and cramps.
On Day 1 went to the hospital that evening 07:00PM my stomach started feeling weird. I was vomiting, had diarrhea and at the same time. My blood pressure was 178/108 at the hospital. When I was talking to the doctor, they kept asking me am I always foggy minded. I was discharged and prescribed nausea medication Odastin 4mg tablets, 600 mg Tylenol. When I left the hospital my blood pressure went down. I had the symptoms for 10 days noticed shortness of breath. I went to get COVID-19 test (results negative) on October 28, 2021. As of today, I feel like I'm getting a lump on the back of my left leg.
Approximately 20 mins after he received covid vaccine, patient got up and began walking with his cane and assistance from his nephew. Patient stopped walking and said "my legs aren't working" and then began to slowly fall. Patient assisted to the floor by his nephew. Dr. notified by MA. Vital signs taken and monitored. Patient remained alert and able to answer questions. Patient denies dizziness, pain, SOB, or any other discomfort. Per nephew, "something feels off about him". BP went to 70s/40s with HR 60s. Notified Dr. and he assessed patient. Patient advised to go to the ED for syncope episode. Nephew agreed with plan and felt comfortable taking pt to the ED now. Patient discharged via wheelchair at 1645.
I received my 1st dose 1/12/21.  I experienced 3 black out spells afterwards. Approx 20 min after shot. Immediately after shot my body got hot and my feet were on fire. On the way home approx 1 1/2 hours afterward my mind was foggy. 2 hours after shot I experienced tachycardia with heart rate  at 138 beats per min and blood pressure 138/94 A friend came over to stay with me cause all I could do is lay down. My legs felt like they weight a ton 3 hours after shot. I had chills and nausea that lasted 48 hours after 1 shot. I am required by my job to get 2nd dose next week.  Do you recommend 2nd dose due to reaction off 1st shot?
Information has been received from a physician concerning an 18 year old female patient who on 05-APR-2007 was vaccinated into the left deltoid with the first dose of GARDASIL (Lot # and route not reported), on 05-JUN-2007, received the second dose into the right deltoid and on 05-OCT-2007 was vaccinated with the third dose into the left deltoid. It was reported that on 17-JUN-2008 the patient was found to have high and low risk HPV by PAP test and Atypical squamous cells of undetermined significance (ASCUS) despite given 3 doses of GARDASIL. The patient's outcome was unknown. On April 2007 a PAP test was performed (result no showed). On 17-Jun-2008 Papanicolaou test was performed which showed atypical squamous cells of undetermined significance with positive high risk HPV (HRHPV) and low risk HPV (LRHPV). On 15-Jul-2008 Papanicolaou test was performed which showed atypical squamous cells of undetermined significance with positive high risk HPV (HRHPV) and low risk HPV (LRHPV). On 10-Nov-2009 Papanicolaou test was performed which showed atypical squamous cells of undetermined significance with positive high risk HPV (HRHPV). 09-Nov-2010 Papanicolaou test was performed which showed atypical squamous cells of undetermined significance with positive high risk HPV (HRHPV). This is one of several reports from the same source. Additional information has been requested.
Mild ringing in my right ear, first noticed a few days after shot.  Most noticeable in the morning when there is no other background noise, but it is persistent.  It does not appear to be getting better or worse, just continues at the same severity.  It has been 2 weeks since shot.